Carisma Therapeutics Joins 7th Annual Evercore ISI HealthCONx Conference To Share Industry Insights

Carisma Therapeutics Inc. (Nasdaq: CARM), a clinical-stage biopharmaceutical company dedicated to pioneering innovative immunotherapies, has announced that Steven Kelly, President and CEO, will take part in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference. The session is scheduled for Thursday, December 5th at 9:35 am ET. An audio webcast of the discussion will be accessible on the Company's Investor Events page within the Investor Relations section of its website and will be available for a limited period after the event.